A malaria gametocytocidal assay using oxidoreduction indicator, alamarBlue
- 30 June 2011
- journal article
- research article
- Published by Elsevier BV in Molecular and Biochemical Parasitology
- Vol. 177 (2), 160-163
- https://doi.org/10.1016/j.molbiopara.2011.02.005
Abstract
No abstract availableKeywords
Funding Information
- Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health
This publication has 20 references indexed in Scilit:
- Effectiveness of five artemisinin combination regimens with or without primaquine in uncomplicated falciparum malaria: an open-label randomised trialThe Lancet Infectious Diseases, 2010
- Thousands of chemical starting points for antimalarial lead identificationNature, 2010
- Flow cytometry for the evaluation of anti-plasmodial activity of drugs on Plasmodium falciparum gametocytesMalaria Journal, 2010
- Effect of Antimalarial Drugs onPlasmodium falciparumGametocytesThe Journal of Infectious Diseases, 2009
- Development of an Alamar Blue™ Viability Assay in 384-Well Format for High Throughput Whole Cell Screening of Trypanosoma brucei brucei Bloodstream Form Strain 427The American Journal of Tropical Medicine and Hygiene, 2009
- In silico activity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screenProceedings of the National Academy of Sciences of the United States of America, 2008
- Gene expression signatures and small-molecule compounds link a protein kinase to Plasmodium falciparum motilityNature Chemical Biology, 2008
- Trioxaquines Are New Antimalarial Agents Active on All Erythrocytic Forms, Including GametocytesAntimicrobial Agents and Chemotherapy, 2007
- A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening AssaysSLAS Discovery, 1999
- The infectivity of gametocytes of Plasmodium falciparum from patients treated with artemisinin.1994